| Improving Risk Stratification in Stage III Colorectal Cancer: An Integrative Analysis of Tumor-Infiltrating Lymphocytes and Tumor Nuclei Features |
Anant Madabhushi |
Emory University |
PLCO |
Aug 8, 2023 |
PLCOI-1283 |
| Development of biomarkers of aging in chest x-ray images using deep learning |
Yasuhito Mitsuyama |
Osaka Metropolitan University |
PLCO |
Aug 8, 2023 |
PLCOI-1285 |
| Transfer Learning for Disease Diagnosis and Therapy Development |
Herschel Rabitz |
Princeton University |
PLCO |
Aug 8, 2023 |
PLCO-1279 |
| Breast Cancer Treatment Plan Research |
Joe Omatoi |
Mercurial-AI |
PLCO |
Jul 19, 2023 |
PLCOI-1262 |
| Exploring the Viability of New Technology to Quickly Determine All Feature Contributions, Feature Value Contributions, Feature Interactions, and Feature Value Interactions that lead to cancer. |
Victor McGuire |
Renown AI, Inc. |
PLCO |
Jul 19, 2023 |
PLCO-1275 |
| Lung cancer prediction model |
Deyao Kong |
Harbin Normal University |
PLCO |
Jul 19, 2023 |
PLCOI-1273 |
| Optimal and Fair Encouragement Designs |
Angela Zhou |
University of Southern California |
PLCO |
Jul 19, 2023 |
PLCO-1271 |
| Evaluation of effects of polygenic risk score, blood biomarkers, and lifestyle behavior on the risk of prostate cancer and colorectal cancer. |
Le Wang |
Zhejiang Cancer Hospital |
PLCO |
Jul 18, 2023 |
PLCO-1270 |
| Development a risk-stratified tool of colonoscopy advanced and nonadvanced adenomas |
Le Wang |
Zhejiang Cancer Hospital |
PLCO |
Jul 6, 2023 |
PLCO-1268 |
| Associations of dietary carrot/carotene intakes with risk of cancer and overall and cause-specific mortality: results from the PLCO Cancer Screening Trial |
Yadong Li |
The Second Affiliated Hospital of chongqing medical university |
PLCO |
Jul 6, 2023 |
PLCO-1266 |
| Role of directly measured metabolic profile as an intermediate between adiposity and endometrial cancer: triangulation of evidence from independent sources |
Laure Dossus |
The International Agency for Research on Cancer, World Health Organization (IARC) |
PLCO |
Jul 3, 2023 |
PLCO-1265 |
| Blood-based biomarkers for personalized risk assessment of breast and ovarian cancers |
Johannes Fahrmann |
University of Texas MD Anderson Cancer Center |
PLCO |
Jul 1, 2023 |
2022-0048 |
| Dietary intake of phytoestrogens and the risk of bladder cancer in the PLCO Screening Trial |
yadong Li |
The Second Affiliated Hospital of chongqing medical university |
PLCO |
Jun 22, 2023 |
PLCO-1261 |
| Characterizing the independent and joint contributions of the chemical, non-chemical, and social-structural environment on cancer incidence and mortality in the PLCO Study |
Jessica Madrigal |
Jessica Madrigal |
PLCO |
Jun 22, 2023 |
PLCO-1259 |
| Impact of treatment options on patient outcomes in hard - to - treat cancers: creating a personalized treatment framework using Machine Learning to address disparities in developed v. LMIC nations’ healthcare |
Georgia Perakis |
Massachusetts Institute of Technology |
PLCO |
Jun 22, 2023 |
PLCOI-1256 |
| In Silico Testing of Hypotheses for the Effect of Smoking on Somatic Evolution in the Healthy Human Lung |
Sam Janes |
University College London |
PLCO |
Jun 22, 2023 |
PLCO-1258 |
| Higher dietary anthocyanidins is associated with reduced risk of biliary cancer in the PLCO Cancer Screening Trial |
Ling Xiang |
Department of Clinical Nutrition, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. |
PLCO |
Jun 22, 2023 |
PLCO-1257 |
| Investigating the Correlation Between Dietary Fiber Intake and Prostate Cancer Progression and Risk Severity |
Bowen Xia |
Capital Medical University |
PLCO |
Jun 15, 2023 |
PLCO-1254 |
| Analyze the effectiveness of CA-125 to detect ovarian and non-ovarian cancer. |
Joel Sokol |
Georgia Institute of Technology |
PLCO |
Jun 13, 2023 |
PLCO-1253 |
| Detection of frameshift mutations in microsatellite instable colorectal cancer in the PLCO Cancer Screening Trial |
Robert Shoemaker |
National Cancer Institute |
PLCO |
Jun 12, 2023 |
2023-0063 |
